
Towards an HIV Cure
AIM: To drive concerted efforts to accelerate global scientific research, advocacy and collaboration towards a cure for HIV
"It is time to more firmly plant the need for an HIV cure on the policy agenda. While interventions that lead to a meaningful cure are at least decades away, we must begin planning for it sooner than later. Once available, we must ensure a cure can be successfully delivered to those countries most burdened by the disease, and delivery must come at speed."
Sharon Lewin
Towards an HIV Cure Advisory Board
Towards an HIV Cure Advisory Board
-
Charu Kaushic, Canadian Institute of Health Research (CIHR), Canada
-
Diana Finzi, NIAID/NIH, United States
-
Florence Thune, Sidaction, France
-
Glaudina Loots, Department of Science & Technology, South Africa
-
Glenda Gray, South African Medical Research Council, South Africa
-
Maureen Goodenow, NIH-OAR, United States
-
Remko van Leeuwen, Aidsfonds, The Netherlands
-
Meg Doherty, WHO, Switzerland
-
Michaela Müller-Trutwin, ANRS and Institut Pasteur, France
-
Mike McCune, Bill & Melinda Gates Foundation, United States
-
Mitchell Warren, AVAC, United States
-
Moses Supercharger Nsubuga, Stigmaless, Uganda
-
Peter Godfrey-Faussett, UNAIDS, Switzerland
-
Richard Jefferys, Treatment Action Group (TAG), United States
-
Rowena Johnston, amfAR, United States
-
Sharon Lewin, The Doherty Institute, University of Melbourne, Australia
-
Steve Deeks, UCSF, United States
-
Thumbi Ndung'u, University of KwaZulu-Natal and AHRI, South Africa
-
Yiming Shao, CDC, China